Parker, Waichman, Alonso LLP

YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)


AddThis Social Bookmark Button

Injured by Campath?

Campath manufactured by Schering and Genzyme Corp. is approved to treat Leukemia. The FDA, on May 7, 2001 approved Campath. On September 16, 2005 Genzyme and Schering suspended dosages in a trial study for Campath after reports of three cases of serious side effects that lead to a death. The Phase II or mid-stage trial side effects consisted of three cases of Idiopathic Thrombocytopenic Purpura (ITP).

Idiopathic Thrombocytopenic Purpura (ITP) is a condition in which patients experience a low platelet count that can cause abnormal bleeding. Genzyme and Schering said they have notified regulatory authorities, trial sites and patients about risks. The companies have consulted a panel of experts to advise the companies on how to reduce risks of ITP.

Treatments for Multiple Sclerosis have recently been under the microscope after the drug Tysabri, made by Elan Corp. and Biogen Idec Inc. was removed from the market in February after it was linked to a rare and potentially fatal brain disease.

If you or a loved one took Campath and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
CampathRSS Feed

US FDA issues warning on Schering's MS drug Campath

Dec 1, 2005 | AFX
The US Food and Drug Administration has issued a warning on the use of Schering AG's multiple sclerosis drug Campath.The FDA said three patients in a clinical study on the drug developed severe idiopathic thrombocytopenic purpura (ITP), a rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.One of the patients died, the FDA said.Campath is so far not approved to treat MS. It is only approved for treating a form of blood cancer...

More Campath News

Campath
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Mailing Address
(include Apt/Suite information)

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News